Expression of class II molecules on intestinal epithelial cells in humans. Differences between normal and inflammatory bowel disease.
about
A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's diseaseRoles for major histocompatibility complex glycosylation in immune functionStimulation of lamina propria lymphocytes by intestinal epithelial cells: evidence for recognition of nonclassical restriction elements.Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study.Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease.Ups and downs of mucosal cellular immunity against protozoan parasites.Crohn disease: a current perspective on genetics, autophagy and immunityIsolation and characterization of intestinal epithelial cells from normal and SIV-infected rhesus macaquesA distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion.Reconstitution of cultured intestinal epithelial monolayers with a mucosal-derived T lymphocyte cell line. Modulation of epithelial phenotype dependent on lymphocyte-basolateral membrane appositionRanitidine, diarrhoea, and lymphocytic colitis.Enterocyte dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin expression in inflammatory bowel diseaseGut barrier function in malnourished patientsSecretory immunoglobulin A in pancreatic juice and pancreatic tissue of patients with chronic pancreatitisInducible nitric oxide synthase activity and expression in a human colonic epithelial cell line, HT-29.Interleukin-8 production by the human colon epithelial cell line HT-29: modulation by interleukin-13Immunomodulatory action of dietary fish oil and targeted deletion of intestinal epithelial cell PPARĪ“ in inflammation-induced colon carcinogenesis.Neutrophil migration across cultured intestinal epithelial monolayers is modulated by epithelial exposure to IFN-gamma in a highly polarized fashionInflammatory bowel disease as a disorder of an imbalance between pro- and anti-inflammatory molecules and deficiency of resolution bioactive lipids.Ligation of intestinal epithelial CD1d induces bioactive IL-10: critical role of the cytoplasmic tail in autocrine signaling.The role of cytokines in inflammatory bowel disease.CD4+ lymphocytes control gut epithelial apoptosis and mediate survival in sepsis.Expression of B7-1 and B7-2 costimulatory molecules by human gastric epithelial cells: potential role in CD4+ T cell activation during Helicobacter pylori infection.Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing.Highly polarized HLA class II antigen processing and presentation by human intestinal epithelial cellsGene expression patterns in experimental colitis in IL-10-deficient miceAnalysis of the toll-like receptor 2-2 (TLR2-2) and TLR4 mRNA expression in the intestinal mucosal immunity of broilers fed on diets supplemented with nickel chloride.Enterocytes: active cells in tolerance to food and microbial antigens in the gut.Defective expression of gp180, a novel CD8 ligand on intestinal epithelial cells, in inflammatory bowel disease.Uroepithelial cells are part of a mucosal cytokine network.Immunocytological responses in porcine proliferative enteropathies.A pathobiont of the microbiota balances host colonization and intestinal inflammation.Tumour necrosis factor-alpha converting enzyme (TACE) activity in human colonic epithelial cells.Effect of gliadin and other food peptides on expression of MHC class II molecules by HT-29 cells.Immunohistochemical changes in the jejunum in first degree relatives of patients with coeliac disease and the coeliac disease marker DQ genes. HLA class II antigen expression, interleukin-2 receptor positive cells and dividing crypt cells.Colonic epithelial cell mediated suppression of CD4 T cell activation.CD1d is involved in T cell-intestinal epithelial cell interactions.Protein transport and processing by human HT29-19A intestinal cells: effect of interferon gamma.Bile acid: a potential inducer of colon cancer stem cells.Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6.
P2860
Q24680126-CC776B99-E1F5-4386-B907-0DAE20046627Q27013984-F35CA29F-68C0-4F2D-8ECF-1D281269949BQ30442871-DAD2A4BC-F1A1-4CD0-85BB-301CB2467491Q33296911-F92BF6D6-F933-464E-A126-BA215C01B074Q34005313-07743943-7B2E-420C-AF62-DD6FF26AC417Q34105722-3FD99D65-D5AA-44FF-A8FB-90C7423CD58FQ34132601-04A84BE4-5CCC-45FF-A050-E1254F05A751Q34145954-3CD19924-4B17-412D-B087-C0276FEB205AQ34192675-6AFD2C26-E495-4B7B-A84C-0486D20A1632Q34229464-983BB9EE-D573-434A-960F-A4036C635E04Q34408910-5200F27B-D6BD-4AA2-8F77-52C9B59CBC68Q34827250-76B0F451-88AB-43D8-B5BE-B7ADE8CE9F7CQ35349952-2713B3E4-78FC-4E77-B0B1-50C5F40B8E8EQ35349988-40B5AA04-E6E3-4C5A-891D-C4C0E6A97280Q35873204-ED49B0AB-32CD-493F-A8D0-0C6482529413Q35884643-08B85CC4-83E9-4577-A75B-560CB183A321Q35939357-B2832DDA-AE39-46C6-98E8-815BF0D3FF22Q36232379-CD8D27A5-BEE9-4DD2-8C9F-6C37A666B4A8Q36461242-003E310E-5FC5-4CF8-898C-FF34C9B48269Q36703897-02F3BCC4-7509-40F6-8238-92E22A7BF34BQ37160344-9511587B-12C7-46FF-930D-F73CC46A6E4FQ37233187-2425DBB7-3D4A-40C2-9956-00E745F98355Q37365656-53B672E7-E437-4C53-805F-61E6E85DDB07Q37369829-ECE69FA8-07DC-46A7-B109-CB7BCCCA3F23Q37384534-E290EC44-0195-4957-ABAA-8D431177024AQ37391156-F7A0E0AD-EF7D-4BD1-9674-0179D44EAF27Q37584038-AD8B2C6F-00F3-48BE-A37F-A559396DE5EDQ37979863-4FEF2E1B-FA76-4021-B2EF-4BA37539A019Q39792621-30340A0A-8EB8-4405-B9C0-2994392350F9Q39860504-97F6BAC2-D2A6-4B2E-9AE4-7A37AE896932Q40148252-84461BFC-87AB-4805-95D8-709EC11A6CE6Q40177229-E8C24A40-C593-4030-AFBF-347981C90320Q40607008-78F02531-D3AD-4708-A040-E2AA8DB5FD6BQ41353475-510918A1-1D2A-4D50-80EE-02139D2D744EQ41982453-8040E7FB-4C95-45F6-8AB5-E58D9AC9CA69Q41984889-92511776-39F2-45D6-AC72-C91B37D34476Q42042602-9E7FC45F-9087-4B8C-875C-7F972FCDD8ACQ42103828-41B5F94A-3B0A-4458-A517-8391CD880B8BQ42359835-2BB9A595-33F8-4438-8ED8-C2B0057E499CQ43086543-5A735078-FA13-424B-9992-D88F03D0C52C
P2860
Expression of class II molecules on intestinal epithelial cells in humans. Differences between normal and inflammatory bowel disease.
description
1991 nĆ® lÅ«n-bĆ»n
@nan
1991幓ć®č«ę
@ja
1991幓č«ę
@yue
1991幓č«ę
@zh-hant
1991幓č«ę
@zh-hk
1991幓č«ę
@zh-mo
1991幓č«ę
@zh-tw
1991幓č®ŗę
@wuu
1991幓č®ŗę
@zh
1991幓č®ŗę
@zh-cn
name
Expression of class II molecul ...... nd inflammatory bowel disease.
@en
type
label
Expression of class II molecul ...... nd inflammatory bowel disease.
@en
prefLabel
Expression of class II molecul ...... nd inflammatory bowel disease.
@en
P2093
P1433
P1476
Expression of class II molecul ...... nd inflammatory bowel disease.
@en
P2093
P407
P577
1991-01-01T00:00:00Z